Michael Joseph McCormack Jr., MD
- Assistant Professor, Hematology and Oncology

Michael Joseph McCormack Jr., MD
Research Interests
- Gastrointestinal Oncology
- Genito-Urinary Oncology
- Education
- BA, Lafayette College, 2007
- MD, Tulane University School of Medicine, 2012
- Residency
- Internal Medicine, Temple University Hospital, 2015
- Fellowship
- Hematology / Oncology, Cooper University Hospital, 2018
- Board Certifications
- American Board of Internal Medicine, Hematology
- American Board of Internal Medicine, Internal Medicine
- American Board of Internal Medicine, Medical Oncology
- Positions
- Assistant Professor, Hematology and Oncology
- Departments and Affiliations
- Hematology and Oncology
Research
- A study using cancer cells in the blood (ctDNA) to predict if chemotherapy will benefit patients who have had surgery for early stage colon cancer
- A study to test the addition of a new anti-cancer drug, M3814 (peposertib), to the usual radiotherapy in patients with locally advanced pancreatic cancer
- A study to compare the drug Enfortumab Vedotin plus Pembrolizumab vs. Neoadjuvant Chemotherapy for Bladder Cancer